Filing metadata

Accession number
0001209191-22-022669
Form type
Form 4
Filer
Outlook Therapeutics, Inc.
CIK
CIK 1649989
Filed
Apr 04, 2022
Reporting period
Mar 31, 2022
Description
Insider transaction

Explore SEC Filings Hub